Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Nuvation Bio stock

Learn how to easily invest in Nuvation Bio stock.

Nuvation Bio Inc is a biotechnology business based in the US. Nuvation Bio shares (NUVB) are listed on the NYSE and all prices are listed in US Dollars. Nuvation Bio employs 85 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Nuvation Bio

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NUVB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Nuvation Bio stock price (NYSE: NUVB)

Use our graph to track the performance of NUVB stocks over time.

Nuvation Bio shares at a glance

Information last updated 2022-10-02.
Latest market close$2.24
52-week range$1.92 - $10.45
50-day moving average $2.69
200-day moving average $4.60
Wall St. target price$4.60
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.42

Buy Nuvation Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Nuvation Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Nuvation Bio price performance over time

Historical closes compared with the close of $2.24 from 2022-09-30

1 week (2022-09-23) 9.27%
1 month (2022-09-02) -23.55%
3 months (2022-07-01) -36.36%
6 months (2022-04-01) -59.27%
1 year (2021-10-01) -77.71%
2 years (2020-10-02) -79.64%
3 years (2019-09-29) N/A
5 years (2017-09-29) N/A

Nuvation Bio financials

Gross profit TTM $0
Return on assets TTM -9.34%
Return on equity TTM -13.94%
Profit margin 0%
Book value $3.18
Market capitalisation $488.9 million

TTM: trailing 12 months

Nuvation Bio share dividends

We're not expecting Nuvation Bio to pay a dividend over the next 12 months.

Nuvation Bio share price volatility

Over the last 12 months, Nuvation Bio's shares have ranged in value from as little as $1.92 up to $10.45. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Nuvation Bio's is 0.392. This would suggest that Nuvation Bio's shares are less volatile than average (for this exchange).

Nuvation Bio overview

Nuvation Bio Inc. , a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an adenosine receptor inhibitor; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as PARP inhibitor to address ER+ breast and ovarian cancer. The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019.

Frequently asked questions

What percentage of Nuvation Bio is owned by insiders or institutions?
Currently 26.93% of Nuvation Bio shares are held by insiders and 71.63% by institutions.
How many people work for Nuvation Bio?
Latest data suggests 85 work at Nuvation Bio.
When does the fiscal year end for Nuvation Bio?
Nuvation Bio's fiscal year ends in December.
Where is Nuvation Bio based?
Nuvation Bio's address is: 1500 Broadway, New York, NY, United States, 10036
What is Nuvation Bio's ISIN number?
Nuvation Bio's international securities identification number is: US67080N1019

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site